It could get interesting if RAC's preclinical for Melanoma evaluates Zantrene in combination with multiple PD-1 inhibitors as speculated by others here on HC before. Whilst a preclinical study is not a clinical trial the results could prove interesting. I wonder if RAC would try a number of PD-1s in their clinical trial - would require multiple arms in the trial.
From the above, the below is a comment by one of the top FDA Cancer Doctors in the New England Journal of medicine.
https://endpts.com/uncoordinated-an...nhibitor-developers-for-creating-a-wild-west/
![]()
The timing could be spectacularly perfect ... and I hope RAC make the most of it in terms of fine-tuning and discussing their plans.
![]()
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-438
-
- There are more pages in this discussion • 1,873 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
0.050(3.08%) |
Mkt cap ! $285.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.75 | $1.64 | $210.4K | 125.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 1.645 |
1 | 12000 | 1.630 |
2 | 4461 | 1.625 |
1 | 5000 | 1.620 |
2 | 10500 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 595 | 1 |
1.695 | 7597 | 2 |
1.700 | 11000 | 1 |
1.730 | 2399 | 1 |
1.750 | 952 | 2 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |